A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 88
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : TIVAD
Long Form : totally implantable venous access device
No. Year Title Co-occurring Abbreviation
2022 Chinese expert consensus on the nursing management of the totally implantable venous access device. ---
2022 Persistent Left Superior Vena Cava Associated with Right Aberrant Subclavian Artery Detected during Totally Implantable Vascular Access Device Insertion. ---
2022 Portacath Implantation in Ghana: Initial Experience at the Komfo Anokye Teaching Hospital in Kumasi. ---
2022 Prolong the flushing and locking interval of TIVAD is feasible in COVID-19: An overview of systematic reviews. SRs
2022 Safety of Insertion of Percutaneous Totally Implantable Central Venous Access Devices by Surgical Residents. ESs, IJV, SRs, SV
2022 Surgical management after Oxaliplatin extravasation: A case report and literature review. ---
2022 Transesophageal echocardiography-guided implantation of totally implantable venous access devices via the internal jugular vein: retrospective analysis of 297 cases in pediatric patients. IJV, TEE
2021 A cluster of grapes: Right atrial masses of uncertain origin. CRAT
2021 A prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy. ---
10  2021 A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review. TIVADs
11  2021 Clinical and dosimetric impact of totally implantable venous access devices in radiotherapy of supra diaphragmatic Hodgkin Lymphoma. 3DCRT, HT, RT
12  2021 Diagnostic error in detection of fractured and migrated totally implantable venous access device fragments and experience with percutaneous retrieval: A report of 27 cases. ---
13  2021 Forty years after the first totally implantable venous access device (TIVAD) implant: the pure surgical cut-down technique only avoids immediate complications that can be fatal. IJV, SCV
14  2021 Image-guided placement of totally implanted vascular access device: retrospective analysis of the clinical outcomes and associated risk factors. ---
15  2021 Pinch-off syndrome from a chemoport catheter successfully managed with endovascular retrieval. POS
16  2021 The effect of chemotherapy type and timing among the other factors on patency of totally implantable vascular access devices in colorectal carcinoma. ---
17  2021 Totally Implantable Venous-Access Device in Maintenance Electroconvulsive Therapy: A Retrospective Case Series. ECT
18  2020 Extending the interval of flushing procedures of totally implantable vascular access devices in cancer patients: It is time for a change. ---
19  2020 Introduction of a specialized consultation prior to insertion of totally implantable access venous devices: Impact on cancellation rate and patient satisfaction. ---
20  2019 Ultrasound-based prediction of cephalic vein cutdown success prior to totally implantable venous access device placement. ---
21  2019 Ultrasound-guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable. ---
22  2019 Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)? PICC
23  2019 Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)? PICC
24  2018 Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients. ---
25  2018 Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs). FIs, TIVADs
26  2018 Pinch-Off Syndrome, a Rare Complication of Totally Implantable Venous Access Device Implantation: A Case Series and Literature Review. POS
27  2018 The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit? WBC
28  2018 Totally Implantable Venous-Access Device Infection Causing Hematogenous Prosthetic Joint Infection: A Retrospective Case Series. PJIs
29  2017 Long-term outcomes of totally implantable venous access devices. HR, PABSI
30  2017 Right or left? Side selection for a totally implantable vascular access device: a randomised observational study. ---
31  2016 Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement. TIVADs
32  2016 Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies. CI, IJV, OR, RCTs, SCV
33  2016 Routine Antibiotic Prophylaxis for Totally Implantable Venous Access Device Placement: Meta-Analysis of 2,154 Patients. PRISMA
34  2016 Totally implantable vascular access device (TIVAD) placement: a modified technique that takes post-procedure aesthetic aspects into account. ---
35  2016 Totally Implantable Venous Access Devices in Children Requiring Long-Term Chemotherapy: Analysis of Outcome in 122 Children from a Single Institution. ---
36  2015 Evaluation of three different techniques for insertion of totally implantable venous access device: A randomized clinical trial. IJB, SCB, US, USG
37  2015 Is there any effect of first-day usage of a totally implantable venous access device on complications? ---
38  2015 Retained embolized fragment of totally implantable central venous catheter in right ventricle: it is really necessary to remove? ---
39  2015 Retrospective evaluation of totally implantable venous access port devices: early and late complications. ---
40  2015 Review of the radiation exposure during screening of surgically implanted central venous access devices. SIVADs
41  2015 [Multicenter validation study of a questionnaire assessing patient satisfaction with and acceptance of totally-implanted central venous access devices]. ---
42  2014 Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study. CF, Doppler-US
43  2014 Fast Track ultrasound protocol to detect acute complications after totally implantable venous access device placement. ---
44  2014 Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved? US
45  2014 Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution. ---
46  2013 Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals. TIVADs
47  2013 Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage. PIVA
48  2013 Routine chest X-ray is not mandatory after fluoroscopy-guided totally implantable venous access device insertion. ---
49  2013 Surgical placement of totally implantable venous access device-an institutional experience. GA
50  2013 Totally implantable venous access device in children with cancer lead to disfiguring scar. mVSS
51  2012 Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest. ---
52  2012 Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study. CF, CFRD
53  2012 Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients. ---
54  2012 Update on totally implantable venous access devices. ---
55  2011 Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy. ---
56  2011 Feasibility and safety of endovascular stripping of totally implantable venous access devices. ---
57  2011 Intravenous electrocardiography helps inexperienced operators to place totally implantable venous access device more accurately. IVECG
58  2011 Systematic review: malfunction of totally implantable venous access devices in cancer patients. ---
59  2011 The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial. ---
60  2011 Ultrasound-assisted percutaneous catheterization of the axillary vein for totally implantable venous access device. ---
61  2010 Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications. ---
62  2010 Outcome of cephalic vein cut-down approach: A safe and feasible approach for totally implantable venous access device placement. CVCD
63  2010 Sensory perceptions of patients with cancer undergoing surgical insertion of a totally implantable venous access device: a qualitative, exploratory study. SIG
64  2009 Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. ---
65  2009 Modification of approach for totally implantable venous access device decreases rate of complications. EJV, SV
66  2009 Skin erosion over totally implanted vascular access devices in children. ---
67  2008 Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis. CF, MVA, RTA, TIVADs
68  2007 A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients. IJ, SC
69  2007 Pulmonary hypertension due to a retained totally implantable venous access device fragment. ---
70  2006 Infection assessment of totally implanted long-term venous access devices. CNS
71  2006 The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children. ---
72  2005 External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement. CV, EJV
73  2005 Prevalence of thrombophilia and catheter-related thrombosis in cystic fibrosis. APA, CF
74  2005 Subclavian vein stenosis following totally implantable venous access device (TIVAD) implant by percutaneous approach. Case report. TIVADs
75  2005 Thrombophilia in children with cystic fibrosis. CF
76  2005 [Assessment of patient's comfort and functioning of a totally implantable venous system placed in the safenous vein]. ---
77  2004 Acute laryngeal paralysis induced by the migration of a totally implantable venous access device's catheter tip. IJV
78  2004 Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices. CRBI
79  2003 [Cephalic vein access for implantable venous access devices. Technique and long-term follow-up]. ---
80  2003 [Complications with totally implantable venous access device. A retrospective of 116 cases]. ---
81  2003 [Importance of nursing in the prevention of complications of totally implantable venous access devices]. ---
82  2002 Totally implanted venous access device removal in interventional radiology. IR
83  2001 A new technique for insertion of totally implantable venous access devices (TIVAD). ---
84  2000 [Use of GEE for modeling censored correlated data: application to the study of risk factors for withdrawal of totally implantable vascular access devices in cystic fibrosis]. GEE
85  1998 Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions. ---
86  1996 Experience with the Port-A-Cath in sickle cell disease. SCD
87  1996 Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients. ---
88  1996 Totally implantable vascular access devices in 131 pediatric oncology patients. ---